RxDoctor Payments Data

Daniel Chamberlain, MD

Radiation Oncology · Rochester, MNNPI 1841269297

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,705 of the $21,369 with a category attached, or 92.2%. AstraZeneca accounts for 98.7% of it on its own, with 3 other manufacturers making up the rest. 2021 is the largest year on record at $12,105, 2.2 times the $5,403 reported in 2019. Among radiation oncology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,369in general payments, 2019–2025

Across 17 payments — averaging $1257.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$21K
  • Boston Scientific$137
  • Medtronic$118
  • Lilly USA, LLC$18

What the payments were for

  • Consulting fees$19,70592%
  • Travel & lodging$1,1926%
  • Food & beverage$4732%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca13$21,096
Boston Scientific2$137
Medtronic1$118
Lilly USA, LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,369 in reported general payments places this provider in the 95th percentile of 128 radiation oncology providers in Minnesota.

See all radiation oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$219,970
Medicare patients
75
Services billed
957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →